Trial Profile
Assessment of Coagulation and Thrombocyte Function After Termination of Ticagrelor in Patients Who Have Previously Undergone PCI Procedures and Insertion of Coronary Stents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2020
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Coronary artery restenosis; Stent thrombosis
- Focus Pharmacodynamics
- 28 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Nov 2014 New trial record